{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:26:06Z","timestamp":1744086366262,"version":"3.40.3"},"reference-count":20,"publisher":"Informa UK Limited","issue":"13","funder":[{"name":"Musculoskeletal disorders"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.2217\/fmb-2018-0202","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T14:45:46Z","timestamp":1539355546000},"page":"1457-1460","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Know Your Enemy: Managing Resistant Gram-Negative Infections"],"prefix":"10.1080","volume":"13","author":[{"given":"Christian","family":"Eckmann","sequence":"first","affiliation":[{"name":"Department of General,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J","family":"Rojas","sequence":"additional","affiliation":[{"name":"Research Service,","place":["Cleveland,, USA"]},{"name":"Department of Molecular Biology & Microbiology,","place":["Cleveland,, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Lyon","sequence":"additional","affiliation":[{"name":"Freelance Medical Writer & Editor,","place":["London,, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"World Health Organization . Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics ( 2017 ). www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/ ."},{"key":"e_1_3_2_3_1","unstructured":"European Centre for Disease Prevention and Control . ECDC Technical Report: Carbapenemase-producing bacteria in Europe ( 2013 ). https:\/\/ecdc.europa.eu\/en\/publications-data\/carbapenemase-producing-bacteria-europe ."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05991-11"},{"key":"e_1_3_2_5_1","unstructured":"European Centre for Disease Prevention and Control . Carbapenemase-producing bacteria in Europe . Interim results from the European survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project 2013 ( 2013 ). https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf ."},{"key":"e_1_3_2_6_1","unstructured":"WHONET Greece . www.mednet.gr\/whonet\/ ."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12655"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01589-17"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12747"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix991"},{"key":"e_1_3_2_11_1","unstructured":"Tartof S KuntzJ ChenLet al. A clinical risk score to predict the likelihood of carbapenem nonsusceptible and pan-\u03b2-lactam nonsusceptibility among adult hospitalized patients with infections due to Pseudomonas aeruginosa . Presented at: European Congress on Clinical Microbiology and Infectious Diseases . Madrid Spain 21\u201324 April 2018 ( Abstract 00130 )."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02166-13"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30228-1"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30099-9"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30112-9"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-380"},{"key":"e_1_3_2_17_1","unstructured":"Sorli L LuqueS CampilloNet al. Colistin for the treatment of symptomatic urinary tract infections caused by extremely drug resistant Pseudomonas aeruginosa: are the current doses of colistin too high? European Congress of Clinical Microbiology and Infectious Diseases . Madrid Spain 21\u201324 April 2018 ( Abstract P2196 )."},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01183-17"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw636"},{"key":"e_1_3_2_20_1","unstructured":"Motsch J De OliveiraC StusVet al. A multicenter randomized double-blind comparator-controlled trial comparing the efficacy and safety of imipenem\/relebactam versus colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections . Presented at: European Congress of Clinical Microbiology and Infectious Diseases . Madrid Spain 21\u201324 April 2018 ( Abstract 00427 )."},{"key":"e_1_3_2_21_1","unstructured":"Tichy E BassettiM EckmannCet al. Cost\u2013effectiveness analysis of ceftazidime\/avibactam (CAZ-AVI) as empirical treatment comparing with meropenem for complicated intra-abdominal infection . Presented: European Congress of Clinical Microbiology and Infectious Diseases . Madrid Spain 21\u201324 April 2018 ( Abstract E0056 )."}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2018-0202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:04:21Z","timestamp":1744063461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2018-0202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.2217\/fmb-2018-0202"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2018-0202","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"type":"print","value":"1746-0913"},{"type":"electronic","value":"1746-0921"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}